CIK: 0001622346 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value ($000): $535,814 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LC | LENDINGCLUB CORP | 19,562,881 | $320,831 | 59.9% | $15.77 | 0.0% | COM | 52603A208 |
| CYH | COMMUNITY HEALTH SYS INC NEW | 27,484,473 | $73,384 | 13.7% | $10.27 | -69.3% | COM | 203668108 |
| HTGC | HERCULES CAPITAL INC | 3,505,755 | $44,944 | 8.4% | $13.02 | -0.4% | COM | 427096508 |
| GOOGL | ALPHABET INC | 26,000 | $28,153 | 5.3% | $43.90 | +30.9% | CAP STK CL A | 02079K305 |
| KKR | KKR & CO INC | 1,080,000 | $27,292 | 5.1% | $24.14 | -7.7% | CL A | 48251W104 |
| AMZN | AMAZON COM INC | 4,000 | $7,575 | 1.4% | $83.14 | +12.0% | COM | 023135106 |
| UBER | UBER TECHNOLOGIES INC | 100,000 | $4,638 | 0.9% | — | — | Call | 90353T100 |
| ALRM | ALARM COM HLDGS INC | 60,000 | $3,210 | 0.6% | $42.83 | +44.1% | COM | 011642105 |
| CRSP | CRISPR THERAPEUTICS AG | 58,158 | $2,739 | 0.5% | $34.76 | +15.0% | NAMEN AKT | H17182108 |
| EDIT | EDITAS MEDICINE INC | 103,579 | $2,563 | 0.5% | $25.00 | -4.5% | COM | 28106W103 |
| KSS | KOHLS CORP | 50,000 | $2,378 | 0.4% | — | — | Call | 500255104 |
| UPWK | UPWORK INC | 126,160 | $2,029 | 0.4% | $17.88 | -3.6% | COM | 91688F104 |
| ARCC | ARES CAP CORP | 103,030 | $1,848 | 0.3% | $7.51 | +25.1% | COM | 04010L103 |
| MEDP | MEDPACE HLDGS INC | 26,882 | $1,759 | 0.3% | $59.44 | -3.0% | COM | 58506Q109 |
| IQV | IQVIA HLDGS INC | 9,224 | $1,484 | 0.3% | $121.14 | +15.8% | COM | 46266C105 |
| PTCT | PTC THERAPEUTICS INC | 30,332 | $1,365 | 0.3% | $16.93 | +133.3% | COM | 69366J200 |
| SGMO | SANGAMO THERAPEUTICS INC | 114,410 | $1,232 | 0.2% | $12.42 | -14.4% | COM | 800677106 |
| — | CARA THERAPEUTICS INC | 54,984 | $1,182 | 0.2% | $12.24 | — | COM | 140755109 |
| LYFT | LYFT INC | 14,700 | $966 | 0.2% | — | — | Call | 55087P104 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 10,000 | $844 | 0.2% | $49.80 | +64.9% | COM | 64125C109 |
| NTLA | INTELLIA THERAPEUTICS INC | 48,657 | $797 | 0.1% | $18.59 | -15.4% | COM | 45826J105 |
| VNDA | VANDA PHARMACEUTICALS INC | 44,787 | $631 | 0.1% | $14.84 | +7.2% | COM | 921659108 |
| AXSM | AXSOME THERAPEUTICS INC | 19,958 | $514 | 0.1% | $5.05 | +297.1% | COM | 05464T104 |
| — | PRA HEALTH SCIENCES INC | 4,980 | $494 | 0.1% | $99.29 | — | COM | 69354M108 |
| — | ZOGENIX INC | 10,000 | $478 | 0.1% | $11.40 | — | COM NEW | 98978L204 |
| — | INTRA CELLULAR THERAPIES INC | 35,278 | $458 | 0.1% | $14.48 | — | COM | 46116X101 |
| — | LABORATORY CORP AMER HLDGS | 2,318 | $401 | 0.1% | $126.40 | — | COM NEW | 50540R409 |
| ICLR | ICON PLC | 2,499 | $385 | 0.1% | $138.12 | +1.5% | SHS | G4705A100 |
| — | CLOUDERA INC | 67,400 | $355 | 0.1% | $11.09 | — | COM | 18914U100 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 10,000 | $331 | 0.1% | $22.63 | +51.4% | COM | 868459108 |
| CRL | CHARLES RIV LABS INTL INC | 2,207 | $313 | 0.1% | $125.21 | +8.3% | COM | 159864107 |
| — | ACORDA THERAPEUTICS INC | 25,957 | $199 | 0.0% | $22.59 | — | COM | 00484M106 |
| — | MARINUS PHARMACEUTICALS INC | 10,000 | $42 | 0.0% | $1.80 | — | COM | 56854Q101 |